申请人:Cha Mi Young
公开号:US20130116213A1
公开(公告)日:2013-05-09
The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.
本发明涉及一种新型融合嘧啶衍生物,具有对酪氨酸激酶的抑制活性,以及一种药物组合物,其作为活性成分用于预防或治疗癌症、肿瘤、炎症性疾病、自身免疫疾病或免疫介导性疾病。